Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Planet Labs PBC (PL) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Planet Labs PBC (PL) over the last 6 years, with Q4 2025 value amounting to $443.3 million.

  • Planet Labs PBC's Cash & Equivalents rose 21902.73% to $443.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $443.3 million, marking a year-over-year increase of 21902.73%. This contributed to the annual value of $118.0 million for FY2025, which is 4070.08% up from last year.
  • Planet Labs PBC's Cash & Equivalents amounted to $443.3 million in Q4 2025, which was up 21902.73% from $181.1 million recorded in Q3 2025.
  • Planet Labs PBC's Cash & Equivalents' 5-year high stood at $496.8 million during Q1 2022, with a 5-year trough of $76.5 million in Q1 2021.
  • In the last 5 years, Planet Labs PBC's Cash & Equivalents had a median value of $139.0 million in 2024 and averaged $188.9 million.
  • As far as peak fluctuations go, Planet Labs PBC's Cash & Equivalents surged by 54909.07% in 2022, and later tumbled by 7129.64% in 2023.
  • Quarter analysis of 5 years shows Planet Labs PBC's Cash & Equivalents stood at $81.2 million in 2021, then surged by 145.34% to $199.1 million in 2022, then tumbled by 49.0% to $101.5 million in 2023, then surged by 36.85% to $139.0 million in 2024, then surged by 219.03% to $443.3 million in 2025.
  • Its Cash & Equivalents was $443.3 million in Q4 2025, compared to $181.1 million in Q3 2025 and $133.5 million in Q2 2025.